Jump to content



Recommended Posts

Hello, I'm new to this board. I received an intresting letter this weekend and thought some of you here would find it interesting also.

The FDA has informed AstraZeneca that they will be taking up to an additional 90 days, until May 5, 2003, to review the new drug application for Iressa as a treatment for advanced NSCLC after disease progression following chemo. It would still be available on a compassionate use basis.

I took Iressa in a clinical trial and didn't have good results. I know some have had improvement or stability of their disease. So it does help some.

Link to comment
Share on other sites

  • 3 months later...

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use. We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.